results posted on April 6, 2022 but not sure if they are positive.
clinicaltrials.gov/ct2/hist...
clinicaltrials.gov/ct2/show...
scienceofparkinsons.com/201...
Can someone get comments from Simon from The Science of Parkinson's ?
EPI-589, PTC-589, (R)-Troloxamide quinone... - Cure Parkinson's
EPI-589, PTC-589, (R)-Troloxamide quinone Phase 2 study results 2022
1 Reply
•
Not what you're looking for?
You may also like...
AnnovisBio has initiated a 6-month Phase 3 study to evaluate 2 different doses Buntanetap (posiphen) in 450 participants with PD
participants with #Parkinsons
https://clinicaltrials.gov/ct2/show/NCT05357989...
29% IMPROVEMENT in Alzheimer's using just 4 supplements in Phase 2 Clinical Study
---------------------------------------------
https://youtu.be/SWM5pyooBBg
The \"UP-study\" phase 2 trial of UDCA Co funded by Cure Parkinson's led by Prof Oliver Bandmann
This looks pretty interesting. UPRDS results did not show any benefit, but UPRDS seems to be like...
Phase 3, the Lighthouse study, Biogen and Denali, LRRK2 inhibitor BIIB122; New clinical trial registered
LRRK2-associated #Parkinsons
https://clinicaltrials.gov/ct2/show/NCT05418673...
Related Posts
Neuraly Announces Topline Results from Phase 2 Trial of NLY01 in Parkinson's Disease- Potential disease-modifying therapy enters Phase 2
Hope Biosciences Stem Cell Research Foundation- Get enrolled in the trial 
Anyone participating in the Buntanetap Phase 3 trial?
Phase 3 Positive Topline Results for Tavapadon
